May 11 (Reuters) - Pediapharm Inc PDP.V :
* Approval triggered second and final payment of us$2
million in cash
* Pediapharm receives fda supplement approval regarding
naproxen suspension in the us, receives additional us$2 million
from atnahs pharma
Source text for Eikon:
Further company coverage: PDP.V
(Bengaluru Newsroom: +1-646-223-8780)